Health Canada approved LipoLaser uses innovative laser technology to
instantly reduce body fat
VANCOUVER, Dec. 3 /CNW/ - Meridian Medical Inc. is pleased to announce
the launch of the Health Canada approved LAPEX 2000 LipoLaser - a
non-invasive, pain-free laser treatment for spot fat reduction and aesthetic
body-forming. Using innovative laser technology, the LipoLaser targets fat
tissue layers, instantly refining and reshaping problem areas including
waistlines, arms, legs, thighs, buttocks and back.
LipoLaser is a stand-alone body-forming laser system, which has received
Health Canada approval and is exclusively distributed by Meridian Medical Inc.
in North America.
"With a single treatment, LipoLaser has the ability to reduce waistlines
and other areas by one to four centimeters on most skin and body types,
setting it apart from any other body-forming aesthetic device on the market,"
said Anna Brazier, president of Meridian Medical Inc. "Doctors have reported
as much as five inches of loss after a standard four week treatment cycle. The
LipoLaser offers clients the luxury of inch loss without having to go under
LipoLaser uses patent and patent-pending technology to externally target
fat cells during each treatment session. Treatments are completely
non-invasive and pain-free, allowing clients to resume normal activities
immediately after each treatment without any residual bruising, swelling or
"Studies have shown that those who eat a healthy diet and exercise
regularly will experience the best LipoLaser results. However, even those with
sluggish metabolisms have reported a unique and invigorating body wake-up,"
During treatments, the fat cells are made temporarily permeable allowing
cell contents to spill out, converting the fat to free fatty acids, water and
glycerol, which in turn are processed through the body's natural metabolic
functions. The body can easily process the amount of mobilized fat released
during a standard treatment cycle.
Low-level laser technology has been used and studied for more than 20
years for a variety of biomedical purposes including wound healing, pain
relief and inflammation.
Meridian Medical conducted an FDA-and Health Canada-requested
double-blind randomized institutional review board study on the safety and
efficacy of the LipoLaser. The study concluded that LipoLaser provided a
significant girth loss, which was maintained over repeated treatments.
The LipoLaser's small size and ease of portability allows trained
technicians to conduct treatments in any small room with a standard electrical
outlet from exam rooms to treatment rooms to the home.
about Meridian Medical Inc.
Meridian Medical Inc. is the exclusive North American distributor of
Meridian Co. Ltd., an established leader in the research/development,
manufacturing and sales of advanced medical devices in the healthcare
industry. With a dynamic research and development team, Meridian is at the
forefront in the development of cutting edge medical technologies. Meridian
presently holds a total of 18 worldwide patents on its technology and has
received FDA approval and Health Canada approval as well as other
international regulatory approvals for many of its products. Meridian has more
than 1,500 clients including physicians, hospitals, clinics, healthcare
professionals and wellness centers in Korea, U.S., Canada, China, Japan and
Europe, and continues to successfully market its superior product line to a
growing number of clients worldwide.
To find out more about Meridian (OTC BB:MRDAF.OB - News), please visit
our website at http://www.meridianmedical.ca
For further information:
For further information: or to schedule an interview, please contact:
Briar Wells, Wilcox Group, (604) 488-1100, email@example.com